Kim Kelderman
2020
In 2020, Kim Kelderman earned a total compensation of $2.2M as President, Diagnostics and Genomics at Bio-Techne, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $464,000 |
|---|---|
| Option Awards | $901,452 |
| Salary | $500,000 |
| Stock Awards | $301,459 |
| Other | $8,400 |
| Total | $2,175,311 |
Kelderman received $901.5K in option awards, accounting for 41% of the total pay in 2020.
Kelderman also received $464K in non-equity incentive plan, $500K in salary, $301.5K in stock awards and $8.4K in other compensation.
Rankings
In 2020, Kim Kelderman's compensation ranked 5,150th out of 13,090 executives tracked by ExecPay. In other words, Kelderman earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,150 out of 13,090 | 61st |
Division Manufacturing | 2,110 out of 5,617 | 62nd |
Major group Chemicals And Allied Products | 843 out of 2,248 | 63rd |
Industry group Drugs | 728 out of 1,948 | 63rd |
Industry Biological Products, Except Diagnostic Substances | 173 out of 411 | 58th |
Source: SEC filing on September 14, 2022.
Kelderman's colleagues
We found four more compensation records of executives who worked with Kim Kelderman at Bio-Techne in 2020.